AUTHORS
Alessandro Putzu et al
European Journal of Anaesthesiology November 03, 2026.
BACKGROUND
Reversal of neuromuscular blockade (NMB) is a routine component of general anaesthesia with important implications for recovery quality and peri-operative safety. Recent changes in the cost of sugammadex, together with its efficacy and adverse effect profile relative to neostigmine, may influence its broader clinical use.
OBJECTIVES
To evaluate the efficacy and safety of sugammadex compared with neostigmine in adult patients.
CONCLUSIONS
Sugammadex probably reverses NMB more rapidly and with fewer adverse events than neostigmine. Broader use of sugammadex has the potential to improve peri-operative outcomes.
KEY POINTS
- A systematic review aimed to evaluate the efficacy and safety of sugammadex versus neostigmine and included 165 trials and over 19 000 adult patients.
- Sugammadex achieved faster recovery time and fewer adverse events than neostigmine.
- Sugammadex may decrease residual neuromuscular blockade, atelectasis, desaturation, airway obstruction, bradycardia, dry mouth and urinary retention.